D. Huw Davies

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination

Travis L. Jensen, Sami R. Cherikh, Johannes B. Goll, 2022, npj Vaccines.

Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination

J. Sattabongkot, J. Sirichaisinthop, G. Yan, 2016, Malaria Journal.

A Protein Microarray-Based Respiratory Viral Antigen Testing Platform for COVID-19 Surveillance

Weian Zhao, P. Felgner, R. Nakajima, 2022, Biomedicines.

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination

Travis L. Jensen, Sami R. Cherikh, Johannes B. Goll, 2022, npj Vaccines.

The antibody landscapes against Group 1 and 2 influenza virus hemagglutinin following AS03 and MF59 adjuvanted H5N1 vaccination

Travis L. Jensen, Sami R. Cherikh, Johannes B. Goll, 2021, medRxiv.

Evaluation of Four Adjuvant Combinations, IVAX-1, IVAX-2, CpG-1826+Montanide ISA 720 VG and CpG-1018+Montanide ISA 720 VG, for Safety and for Their Ability to Elicit Protective Immune Responses in Mice against a Respiratory Challenge with Chlamydia muridarum

P. Felgner, J. Felgner, S. Pal, 2023, Pathogens.

Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cells

Johannes S. Gach, D. Forthal, Melissa N. Thone, 2023, Cellular Immunology.